US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Svas Biosana (SVS) 銘柄情報

Svas Biosana (SVS)

9.44

-0.30

(-3.08%)

終了 6月14日 12:30AM

Svas Biosana (SVS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

9.44

( -3.08% )

買値

9.30

売値

9.60

出来高

1,368

9.44 日の範囲 9.74

7.42 52 週間の範囲 10.80

時価総額

前日終値

9.74

始値

9.74

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

4,217 €

発行済株式数

5,222,906

配当利回り

(2.67%)

PER

7.25

1 株当たり利益 (EPS)

1.29

歳入

141.56M

純利益

6.77M

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medica... SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in oncology, intensive care, chronic illnesses, and surgeries; and medical devices for use in radiology and diagnostic imaging, orthopaedics, cardiology, heart surgery, and critical care applications. SVAS Biosana S.p.A. was founded in 1972 and is based in Somma Vesuviana, Italy. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

svas.it

本社

Somma Vesuviana, Italy

設立

1972

Svas Biosana is listed in the Healthcare sector of the イタリア証券取引所 with ticker SVS. The last closing price for Svas Biosana was 9.74 €. Over the last year, Svas Biosana shares have traded in a share price range of 7.42 € to 10.80 €.

Svas Biosana currently has 5,222,906 shares in issue. The market capitalisation of Svas Biosana is 49.30 € million. Svas Biosana has a price to earnings ratio (PE ratio) of 7.25.

Trading Statement

RNS Number:7051U Savills PLC 28 January 2004 28 January 2004 SAVILLS PLC ("Savills") Savills gives further guidance on 2003 results...

Director Shareholding

RNS Number:6640U Savills PLC 27 January 2004 Savills plc - 27 January 2004 NOTIFICATION TO THE STOCK EXCHANGE OF DIRECTORS' INTERESTS...

Re Alliance

RNS Number:5556U Savills PLC 22 January 2004 Thursday 22 January 2004 SAVILLS PLC ("Savills") Savills plc and Trammell Crow Company...

Repurchase of shares

RNS Number:4933U Savills PLC 21 January 2004 On the 21st January 2004, Savills plc acquired from Hoare Govett's affiliate, ABN AMRO Equities...

Holding(s) in Company

RNS Number:3522U Savills PLC 16 January 2004 NOTIFICATION OF MAJOR INTERESTS IN SHARES Notice was received today, 16 January 2004...

Director Shareholding

RNS Number:1355U Savills PLC 12 January 2004 Savills plc - 12 January 2004 NOTIFICATION TO THE STOCK EXCHANGE OF DIRECTORS' INTERESTS...

Purchase of own securities

RNS Number:0305U Savills PLC 08 January 2004 Savills plc Repurchase of Shares On the 8th January 2004, Savills plc acquired from...

Director Shareholding

RNS Number:8707T Savills PLC 05 January 2004 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF COMPANY SAVILLS...

Director Shareholding

RNS Number:8699T Savills PLC 05 January 2004 Savills plc 5 January 2004 NOTIFICATION TO THE STOCK EXCHANGE OF DIRECTORS' INTERESTS IN...

Purchase of own securities

RNS Number:7450T Savills PLC 30 December 2003 For immediate release 30 December 2003 SAVILLS plc Close Period Share Re-purchase...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-0.211416490486	9.46	9.78	9.16	3376	9.61203293	DE
4	0.44	4.88888888889	9	9.84	8.88	2296	9.35698628	DE
12	1.5	18.8916876574	7.94	9.84	7.92	4023	9.00282609	DE
26	0.88	10.2803738318	8.56	9.84	7.68	3099	8.83801495	DE
52	1.4	17.4129353234	8.04	10.8	7.42	4542	8.87005923	DE
156	1.74	22.5974025974	7.7	10.8	6.48	3972	8.24341873	DE
260	-5.51	-36.856187291	14.95	16.3	6.48	4389	9.53610591	DE

SVS - Frequently Asked Questions (FAQ)

What is the current Svas Biosana share price?

The current share price of Svas Biosana is 9.44 €

How many Svas Biosana shares are in issue?

Svas Biosana has 5,222,906 shares in issue

What is the market cap of Svas Biosana?

The market capitalisation of Svas Biosana is EUR 49.3M

What is the 1 year trading range for Svas Biosana share price?

Svas Biosana has traded in the range of 7.42 € to 10.80 € during the past year

What is the PE ratio of Svas Biosana?

The price to earnings ratio of Svas Biosana is 7.25

What is the cash to sales ratio of Svas Biosana?

The cash to sales ratio of Svas Biosana is 0.35

What is the registered address of Svas Biosana?

The registered address for Svas Biosana is Via Trentola, 7, Somma Vesuviana, Naples

What is the Svas Biosana website address?

The website address for Svas Biosana is svas.it

Which industry sector does Svas Biosana operate in?

Svas Biosana operates in the Medical Equipment & Supplies sector

02opida

02opida 5分前

BBANBOB

BBANBOB 5分前

WATCH HOW IT FOES DOWN as I think you are going to not only be shocked but very wrong, JUST SAYING

02opida

02opida 5分前

02opida

02opida 6分前

02opida

02opida 6分前

02opida

02opida 6分前

02opida

02opida 6分前

erg61

Have you ever considered it’s because of greedy unscrupulous posters like you and others along with greedy HF companies like the seven being sued that is what forces NWBO to take certain actions and follow the course they are following? Why do you post 24/7?

02opida

02opida 6分前

02opida

02opida 6分前

02opida

02opida 6分前

nowwhat2

nowwhat2 7分前

Yes cool story / Cool interview

02opida

02opida 7分前

Sunday Morning Hi BBCMF'ers

Bullish Green

Bullish Green 8分前

I just did a year's worth of catching up....

For nothing.

02opida

02opida 9分前

02opida

02opida 9分前

VIVK...................................https://stockcharts.com/sc3/ui/?s=VIVK&p=d&yr=0&mn=2&dy=12&id=p84071410134

BBANBOB

BBANBOB 10分前

Well in short ifin ya don't understand JMW still has 100% control over her orders in the GSA being carried out also they are revamping the 5th circuit court in the SDNY.
THe case may not be over "WE RECEIVED NOTHING IN RETURN"" but could easily be filed WE DID NOT RECIEVE what was AGREED TO

fredscott36

fredscott36 11分前

.........FCNCA, bobbie..........levered into our cargo shorts......with the FDIC cash...........

.....ART OF THE DEAL = = = do not engage with THE DEVIL.....ever......USA citizenry ain't got anything to gain by playing games with ragheads.......albeit in support of ZION............

imanjen13

imanjen13 11分前

While the timeline for approval for the Oxy ANDA is unknown, if the usual timeframe of 9 months prevails, Elite should get the notification no later then December if not sooner considering the lifting of the stay. This should add nice value to Elite for a potential merger /acquisition partner. This

erg61

I understand that. I was just thinking about what humans value. Money, profit, greed. Human suffering is on the back burner when it comes to profit and greed. Space exploration does not bring relief to suffering humans. The point I was making is people like investor082 and others try to destroy some

porty

Does anyone know the vessel 2 total so far? Is it this .25?

Preciouslife1

Preciouslife1 13分前

https://www.facebook.com/reel/1528335098780464/?fs=e&fs=e THE MIZ, WHIZ, 105 MPH!

magikalalpha

magikalalpha 17分前

My OTC swing scanner flagged it this morning: DEATH_X. The 50-day moving average has crossed below the 200-day. Bearish long-term confirmation.
The technicals are catching up to the balance sheet:
$1,187 cash on hand
$0 revenue
$32.8M accumulated deficit
Woolen

Utsmaro71

Utsmaro71 18分前

Clarke and Brooks both need to shoot 62 or 63

JFE Systems (PK)

Zoom Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。